Fortress Biotech Inc FBIO Fundamentals and Key Ratios

Fortress Biotech Inc. (FBIO) Fundamentals


Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

SHARE INFORMATION
Market Cap	$ 101,131,650
Shares Outstanding	108,615,240
Float	80,124,688
Percent Float	73.77%
Short Interest	0.00
Short Percent Float	0.0%
Short Interest Ratio	0.00
Short Interest Date	-
Latest Fiscal Dividend Per Share	$ 0.00
Latest Fiscal Revenue	$ 68,791,000
Latest Fiscal EPS	$ -0.79
Latest Fiscal Date	2021-12-31

DIVIDENDS
Dividend (3 Years)	$ 0.00
Dividend (5 Years)	$ 0.00
Ex Dividend Date	-
Dividend Rate	$ 0.00
Dividend Yield	0.0%
Payment Cash	-

HOLDERS
Institutions	181
Institutional Holdings Date	2022-12-31
Institutional Bought Previous 3 Months	1,683,682
Institutional Holdings Percent	39.9%
Institutional Sold Previous 3 Months	7,914,884
Insider Holdings Date	2022-12-31
Insider Bought Previous 3 Months	1,590,000
Insider Holdings Percent	28.5
Insider Sold Previous 3 Months	-
Insider Shares Owned	30,959,512

TRADING INFO
52 Week High	$ 2.16
52 Week Low	$ 0.48
52 Week High Change	$ -52.25
21 Day Moving Average	$ 0.8337
21 Day Extended Moving Average	$ 0.860907
50 Day Moving Average	$ 0.7415
50 Day Extended Moving Average	$ 0.798847
200 Day Moving Average	$ 0.889781
200 Day Extended Moving Average	$ 1.0616
10 Day Average Volume	680,639
20 Day Average Volume	770,022
30 Day Average Volume	639,138
50 Day Average Volume	465,071
Alpha	-0.014553
Beta	1.7803
Standard Deviation	0.269480
R2	0.126908
7 Day Price Change	$ -0.0989
7 Day Percent Change	-9.6%
21 Day Price Change	$ 0.1411
21 Day Percent Change	17.86%
30 Day Price Change	$ 0.4136
30 Day Percent Change	79.92%
Month to Date Price Change	$ 0.2761
Month to Date Percent Change	42.15%
Quarter to Date Price Change	$ 0.2761
Quarter to Date Percent Change	42.15%
180 Day Price Change	$ 0.0331
180 Day Percent Change	3.69%
200 Day Price Change	$ 0.0372
200 Day Percent Change	4.16%
Year to Date Price Change	$ 0.2761
Year to Date Percent Change	42.15%

PROFITABILITY
EBIT Margin	-275.1%
EBITDA Margin	-264.2%
Pre-Tax Profit Margin	-282.9%
Profit Margin Count	0.0%
Gross Margin	56.6%
Profit Margin TOT	0.0%

INCOME STATEMENTS
Revenue	$ 59,339,000
Revenue Per Share	$ 0.5463
Revenue (3 Years)	$ 0.00
Revenue (5 Years)	$ 0.00

FINANCIAL STRENGTH
Price to Tangible Book	3.00
Total Debt To Equity	2.00
Int Coverage	-19.40
Current Ratio	2.40
Leverage Ratio	4.60
Quick Ratio	2.20
Long Term Debt To Capital	0.65

VALUATION MEASURES
PE Ratio	-0.90
Enterprise Value	$ 18,189,649
Price to Sales	1.7043
Price to Free Cash	-0.60
PE High Last 5 Years	-1.40
Price To Book	1.60
Price To Cash Flow	0.00
PE Low Last 5 Years	-3.70
Price to Tangible Book	3.00

MANAGEMENT EFFECTIVENESS
Receivables Turnover	2.40
Invoice Turnover	2.70
Assets Turnover	0.20
Return Assets	-27.26
Return on Equity	-130.13
Return on Capital	-44.48

PROFILE INFO
Issue Type	CS
SEC Type	EQS
Auditor	KPMG LLP
CEO	Lindsay A. Rosenwald
Emplyoees	173
Last Audit	UQ
CIK	0001429260
Industry	Biotechnology
Sector	Healthcare
NAICS	Pharmaceutical Preparation Manufacturing(325412)

CONTACT INFO
Address	1111 Kane Concourse Suite 301 Bay Harbor Island, FL 33154
Website	https://www.fortressbiotech.com
Facsimile	+1 781 459-7788
Telephone	+1 781 652-4500
Email	ir@fortressbiotech.com

Quotes:

IHub:

FBIO

Fortress Biotech Inc. (FBIO) Fundamentals

Fortress Biotech Inc. (FBIO) Key Ratios

Fortress Biotech Inc. (FBIO) Profile